Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 9/20 | 0.67 |
| ▸ | CNR1 | P21554 | 8/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.67 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.59 |
| ▸ | USP2 | O75604 | 1/20 | 0.50 |
| ▸ | LPAR6 | P43657 | 2/20 | 0.49 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.49 |
| ▸ | LPAR4 | Q99677 | 2/20 | 0.49 |
| ▸ | LPAR5 | Q9H1C0 | 2/20 | 0.49 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.49 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28396798 | 1.00 | CNR2 (0.67) | CNR2CNR1ALDH1A1DNM1USP2 | |
| SCHEMBL2216579 | 1.00 | CNR2 (0.67) | CNR2CNR1ALDH1A1DNM1USP2 | |
| SCHEMBL2217627 | 1.00 | CNR2 (0.67) | CNR2CNR1ALDH1A1DNM1USP2 | |
| SCHEMBL29511938 | 1.00 | CNR2 (0.67) | CNR2CNR1ALDH1A1DNM1USP2 | |
| SCHEMBL3793537 | 1.00 | CNR2 (0.67) | CNR2CNR1ALDH1A1DNM1USP2 | |
| SCHEMBL2342987 | 1.00 | CNR2 (0.67) | CNR2CNR1ALDH1A1DNM1USP2 | |
| SCHEMBL9243523 | 1.00 | CNR2 (0.67) | CNR2CNR1ALDH1A1DNM1USP2 | |
| SCHEMBL2218924 | 1.00 | CNR2 (0.67) | CNR2CNR1ALDH1A1DNM1USP2 | |
| SCHEMBL6417540 | 1.00 | CNR2 (0.67) | CNR2CNR1ALDH1A1DNM1USP2 | |
| SCHEMBL2340727 | 1.00 | CNR2 (0.67) | CNR2CNR1ALDH1A1DNM1USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-5017495-A | — | — | None | — | — | JP | disclosed |
| CN-103025304-B | Cosmetic composition based on supramolecular polymer and absorbent filler | OU LAIYA (FR) | 2016-06-01 | — | — | CN | disclosed |
| CN-103037836-B | For the beauty method of making up to skin and/or lip and/or nursing | OU LAIYA (FR) | 2016-02-03 | — | — | CN | disclosed |
| EP-2827830-A2 | PRESERVATIVE COMPOSITION AND COSMETIC PRODUCTS CONTAINING SAME | Henkel AG & Co. KGaA (DE) | 2015-01-28 | — | — | EP | disclosed |
| WO-2013091978-A2 | PRESERVATIVE COMPOSITION AND COSMETIC PRODUCTS CONTAINING SAME | HENKEL AG & CO. KGAA (DE) | 2013-06-27 | — | — | WO | disclosed |
| EP-2426099-A1 | Coalescent for aqueous compositions | Rohm and Haas Company (US) | 2012-03-07 | — | — | EP | disclosed |
| US-20120052210-A1 | COALESCENT FOR AQUEOUS COMPOSITIONS | VAN DYK ANTONY KEITH (US) | 2012-03-01 | — | — | US | disclosed |
| JP-H0517495-A | BISGLYCOSIDE AND DIOL | BASF AG | 1993-01-26 | — | — | JP | disclosed |
| US-5126441-A | Biodegradable nonionic surfactants or emulsifiers | BASF AKTIENGESELLSCHAFT (DE) | 1992-06-30 | — | — | US | disclosed |
| EP-0442371-A2 | Bisglycosides | BASF Aktiengesellschaft (DE) | 1991-08-21 | — | — | EP | disclosed |
| WO-1991005558-A1 | USE OF LECITHIN ANALOGS AS ANTIVIRAL DRUGS AS WELL AS NEW COMPOUNDS | BOEHRINGER MANNHEIM GMBH (DE) | 1991-05-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120052210-A1 | COALESCENT FOR AQUEOUS COMPOSITIONS | DGAT2, DGAT1, DAGLB | CNR2 333/4885CNR1 362/4885ALDH1A1 3271/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.